Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study)
Home Blood Pressure Registration Study on Community Elderly Population(HOME Study)
研究概览
地位
地位
干预/治疗
干预/治疗
详细说明
Study population includes subjects who living in community, of any race or ethnicity, 65 or older years of age, and have provided written informed consent to provide home blood pressure monitoring at one or more study visits.
Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.
研究类型
研究类型
注册 (预期的)
注册
联系人和位置
学习联系方式
学习联系方式
- 姓名:Feng Ying-qing, PhD
- 电话号码:+862083827812
- 邮箱:651792209@qq.com
学习地点
-
-
Guangdong
-
Guangzhou、Guangdong、中国、510080
- 招聘中
- Guangdong Provincial People's Hospital
-
接触:
- FENG Ying-qing
- 电话号码:02083827812
- 邮箱:fyq1819@163.com
-
Guangzhou、Guangdong、中国、510080
- 尚未招聘
- Feng Yingqing
-
接触:
- Feng Ying-qing, PhD
- 电话号码:+862083827812
- 邮箱:651792209@qq.com
-
-
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
•≥65 years old
- Signed informed consent
- Life expectancy is greater than 1 year
Exclusion Criteria:
- <65 years old
- Unsigned informed consent
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
All-Cause Mortality
大体时间:From date of inclusion until the date of death from any cause, assessed up to 1 year
|
All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.
|
From date of inclusion until the date of death from any cause, assessed up to 1 year
|
|
Cardiovascular Mortality
大体时间:From date of inclusion until the date of death from any cause, assessed up to 1 year
|
Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).
|
From date of inclusion until the date of death from any cause, assessed up to 1 year
|
次要结果测量
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
心血管疾病的次要结局
大体时间:通过学习完成,平均1年
|
心血管疾病的数量和发病率。
|
通过学习完成,平均1年
|
|
脑血管疾病的次要结局
大体时间:通过学习完成,平均1年
|
脑血管病的发病率。
|
通过学习完成,平均1年
|
|
Secondary outcomes of kidney
大体时间:Through study completion, an average of 1 years
|
The incidence rate of renal injure and end-stage renal disease
|
Through study completion, an average of 1 years
|
|
Secondary outcomes of hypertension
大体时间:Through study completion, an average of 1 years
|
The incidence rate of hypertension
|
Through study completion, an average of 1 years
|
|
Secondary outcomes of diabetes
大体时间:Through study completion, an average of 1 years
|
The incidence rate of diabetes
|
Through study completion, an average of 1 years
|
其他结果措施
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of participants with reported hospitalization due to other diseases
大体时间:From date of inclusion until the date of first event, assessed up to 1 year
|
The incidence rate of tumor, fracture, cataract etc.
|
From date of inclusion until the date of first event, assessed up to 1 year
|
合作者和调查者
调查人员
调查人员
- 学习椅:Feng Ying-qing, PhD、Guangdong Provincial People's Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
学习开始
初级完成 (预期的)
初级完成
研究完成 (预期的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.